Single-agent therapy for infections in neutropenic cancer patients
- 9 August 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (2) , 83-88
- https://doi.org/10.1016/0002-9343(85)90266-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinThe American Journal of Medicine, 1982
- Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsAntimicrobial Agents and Chemotherapy, 1980
- Mezlocillin for treatment of infections in cancer patientsAntimicrobial Agents and Chemotherapy, 1980
- A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with MalignanciesMedicine, 1979
- Mezlocillin: In Vitro Studies of a New Broad-Spectrum PenicillinAntimicrobial Agents and Chemotherapy, 1977
- β-Lactum antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patientsThe Lancet Healthy Longevity, 1976
- Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-TobramycinAntimicrobial Agents and Chemotherapy, 1975
- Ticarcillin Therapy of InfectionsAntimicrobial Agents and Chemotherapy, 1973
- Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rodsCancer, 1973
- Carbenicillin Therapy of Gram-Negative Bacilli InfectionsThe Lancet Healthy Longevity, 1969